Vyleesi (bremelanotide) prior authorization form coverage criteria
Customize your policy alerts
Sign up for all Highmark West Virginia policy alerts
Know when Highmark West Virginia releases new policies or updates existing guidance.
Monitor payer policy activity
This document is a prior authorization request form for Vyleesi (bremelanotide) for treatment of hypoactive sexual desire disorder (HSDD) in premenopausal females; it governs information providers must supply to request initial or reauthorization of therapy from Highmark West Virginia.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.